← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #251 OF 1,000 MOST-CITED

Safety lighting and glass

FDA cited this observation 89 times across 89 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods89
BY FISCAL YEAR
FY20201
FY20195
FY201827
FY201756

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 1.2× the rate of the average FDA-cited firm (10.1% vs 8.3%), across 89 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your Professional access…

How FDA worded it — real examples

Failure to provide safety-type light bulbs suspended over exposed food.

Blue Front Bar-B-Que, Inc. · Lake Worth, Florida · Foods · 2020-03-12

Failure to provide safety-type light bulbs suspended over exposed food.

Get Drizzled Custom Wine Drizzle, LLC · Mayview, Missouri · Foods · 2019-04-23

Failure to provide safety-type lighting fixtures suspended over exposed food.

Fashion Fabs · Kannur · Foods · 2019-04-03

Failure to provide safety-type light bulbs suspended over exposed food.

LDR Colorado, LLC · Denver, Colorado · Foods · 2019-04-03

Failure to provide safety-type light bulbs and lighting fixtures suspended over exposed food.

New York Bottling Co. Inc. · Bronx, New York · Foods · 2019-04-01

Failure to provide safety-type light bulbs suspended over exposed food.

Cornell Beverages Inc · Brooklyn, New York · Foods · 2019-03-21

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Food industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →